Submitted by Anonymous (not verified) on 20 October 2026 - 10:45
Human medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Columvi, glofitamab, Date of authorisation: 07/07/2023, Revision: 6, Status: Authorised